Although deregulation of ferroptosis is of interest in cancer therapy, the molecular mechanisms that govern its regulation remain unclear. A study now identifies TMEM87a as a mediator of ferroptosis resistance, establishing a mechanistic link to Golgi pH homeostasis, and explores its relevance to immune checkpoint therapy.
- Vasanthi S. Viswanathan
- John K. Eaton